Cancer Crosslinks, arranged in person in Oslo and as a digital event, promotes interactions between researchers and clinicians, and encourages translational and clinical research.
This event has become a leading forum, gathering oncologists, hematologists, translational researchers, healthcare providers, regulatory experts, and industry representatives. The hallmark of Cancer Crosslinks is the educational program featuring international and Norwegian experts presenting recent advances in oncology. The educational program is complemented by activities to stimulate additional interactions and discussions between speakers and representatives from the oncology community.
The 2022 event will include updates about the most recent progress in the understanding of tumor evolution, as well as emerging diagnostic and treatment options for solid and hematological cancers. Confirmed speakers include Mariam Jamal-Hanjani, Group leader, UCL Cancer Institute, and David Rimm, Professor of Pathology and Medicine, Yale University School of Medicine.
Read more about Cancer Crosslinks here!
Photo of Mariam Jamal-Hanjani, Group leader, UCL Cancer Institute, one of the speakers at Cancer Crosslinks